127 related articles for article (PubMed ID: 32347175)
1. Is the Quality of Generic Drugs Cause for Concern?
Hussar DA
J Manag Care Spec Pharm; 2020 May; 26(5):597-599. PubMed ID: 32347175
[TBL] [Abstract][Full Text] [Related]
2. Can We Trust the Quality of Generic Drugs?
Eban K
J Manag Care Spec Pharm; 2020 May; 26(5):589-591. PubMed ID: 32347179
[TBL] [Abstract][Full Text] [Related]
3. A Physician's Perspective on Generic Drug Quality.
Lever HM
J Manag Care Spec Pharm; 2020 May; 26(5):592-593. PubMed ID: 32347170
[TBL] [Abstract][Full Text] [Related]
4. THE MOST FAVORED NATIONS MODEL INTERIM FINAL RULE IS FATALLY FLAWED AND MUST BE RESCINDED-YET THE PROBLEM IT ADDRESSES DEMANDS A SOLUTION.
Rubinstein E
J Manag Care Spec Pharm; 2021 Feb; 27(2):286. PubMed ID: 33506733
[No Abstract] [Full Text] [Related]
5. Traversing the Quality Chasm: Revisiting the Framework for Pharmacy Services Quality Improvement.
Nelson ML; Chapman C; Campbell PJ
J Manag Care Spec Pharm; 2020 Jul; 26(7):817-819. PubMed ID: 32584683
[TBL] [Abstract][Full Text] [Related]
6. Employer and Plan Sponsor Views on Pharmacy Reimbursement.
Stull M; Gupton C
J Manag Care Spec Pharm; 2020 Jun; 26(6):710-712. PubMed ID: 32463776
[TBL] [Abstract][Full Text] [Related]
7. FDA comments on activities in states concerning narrow-therapeutic-index drugs.
Am J Health Syst Pharm; 1998 Apr; 55(7):686-7. PubMed ID: 9558425
[No Abstract] [Full Text] [Related]
8. A Call to Action to Track Generic Drug Quality Using Real-World Data and the FDA's Sentinel Initiative.
Brown JD
J Manag Care Spec Pharm; 2020 Aug; 26(8):1050. PubMed ID: 32715968
[TBL] [Abstract][Full Text] [Related]
9. Four-dollar generics--increased accessibility, impaired quality assurance.
Choudhry NK; Shrank WH
N Engl J Med; 2010 Nov; 363(20):1885-7. PubMed ID: 21067379
[No Abstract] [Full Text] [Related]
10. Generic medicines--can quality be assured?
Drug Ther Bull; 1997 Feb; 35(2):9-11. PubMed ID: 9282412
[TBL] [Abstract][Full Text] [Related]
11. Assessing the Quality of Pharmacy Care: It's Not About Adherence.
Rupp MT
J Manag Care Spec Pharm; 2019 Oct; 25(10):1046-1047. PubMed ID: 31556819
[TBL] [Abstract][Full Text] [Related]
12. Evolution of the Pharmacy Benefit Manager/Community Pharmacy Relationship: An Opportunity for Success.
Taddei-Allen P
J Manag Care Spec Pharm; 2020 Jun; 26(6):708-710. PubMed ID: 32463767
[TBL] [Abstract][Full Text] [Related]
13. Bioequivalence/bioavailability retention samples.
Ransom C
Qual Assur; 1993; 2(1-2):42-3. PubMed ID: 8156218
[No Abstract] [Full Text] [Related]
14. The Tiered Pharmacy Benefit: Challenges in Today's Health Care Market.
Kenney JT
J Manag Care Spec Pharm; 2020 May; 26(5):586-587. PubMed ID: 32347178
[TBL] [Abstract][Full Text] [Related]
15. Evaluating the outcomes of pharmaceutical care.
Lipowski EE
J Am Pharm Assoc (Wash); 1996 Dec; NS36(12):726-34; quiz 734-6. PubMed ID: 8990758
[No Abstract] [Full Text] [Related]
16. Assuring quality pharmacy services.
Snodgrass G; Lamnin M
Contemp Adm Long Term Care; 1983 Apr; 6(4):13-4. PubMed ID: 10295250
[No Abstract] [Full Text] [Related]
17. Moving Pharmacy Benefits from Nice to Have to Essential Benefits.
Caldwell KA; Edgar B
J Manag Care Spec Pharm; 2020 Aug; 26(8):943-944. PubMed ID: 32715963
[TBL] [Abstract][Full Text] [Related]
18. The brand of generic prescriptions.
Gangadhar BN; Chaturvedi SK
Indian J Med Ethics; 2018; 3(1):84-85. PubMed ID: 29477986
[No Abstract] [Full Text] [Related]
19. Decision makers need an approach to determine digital therapeutic product quality, access, and appropriate use.
Parcher B; Coder M
J Manag Care Spec Pharm; 2021 Apr; 27(4):536-538. PubMed ID: 33769855
[No Abstract] [Full Text] [Related]
20. Pharmacist is link to improved systems, quality, and outcome.
Martin H
Provider; 1993 Dec; 19(12):47. PubMed ID: 10130673
[No Abstract] [Full Text] [Related]
[Next] [New Search]
